Advagen Pharma Recalls Metoprolol Tartrate Tablets Due to Foreign Tablets
Advagen Pharma Limited has issued a recall for 50 mg Metoprolol Tartrate Tablets because foreign tablets or capsules were found in bottles.
Advagen Pharma Limited is recalling 3,684 bottles of Metoprolol Tartrate Tablets, USP, 50 mg, packaged in bottles of 1,000 tablets.
The recall was published by the FDA due to the presence of foreign tablets or capsules found within the medication bottles, posing potential safety hazards.
The prescription product was distributed nationwide across the United States. The FDA designated this as a Class II recall.
What to do
- Stop using the recalled medication if you find any unexpected or foreign tablets inside the bottle.
- Contact your doctor or pharmacist immediately to discuss obtaining an alternative prescription.
- Reach out to Advagen Pharma Limited or the FDA if you have questions regarding this recall.
At a glance
| Agency | U.S. Food and Drug Administration (FDA) |
|---|---|
| Recall number | D-0182-2027 |
| Date | 2026-11-11 |
| Company | Advagen Pharma Limited, East Windsor, NJ |
| Severity | Class II |
| Quantity | 3684 bottles |
| Where sold | U.S. Nationwide |
| Lot codes / identifiers | Batch#: 2611C065A1: Expiry: 05/2028 |
Source: official FDA notice. This summary was written by 365 News from the official notice. Details can change; check the notice before acting.